根据条款,AnnJi将获得300万美元的预付款,并有权获得未来的开发、监管和商业化里程碑付款,以...查看全文
港美情报站2022-09-23 18:02
与葛兰素史克签大单!$Spero治疗(SPRO)$ 荣登妖股涨幅榜榜首
医药股历来是妖股集中营,昨日#美股# 涨幅前二的#妖股# 都是生物医药行业。昨日妖股涨幅榜榜首是SPRO,盘中最大涨幅接近300%,收盘涨幅也有167%。
消息面上,昨日,葛兰素史克和Spero Therapeutics已就tebipenem pivoxil hydrob...查看全文
格隆汇4月18日丨Avenue Therapeutics盘前涨15.65%,报1.33美元。Avenue Therapeutics周一表示,3月9日与美国FDA就开发用于治疗术后疼痛的静脉注射曲马多(IV Tramadol)举行的官方纪要表明,该机构在拟议研究方案... 网页链接
$Avenue Therapeutics(ATXI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-20-020235 Size: 5 KB 网页链接
$Avenue Therapeutics(ATXI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-20-020237 Size: 5 KB 网页链接
$Avenue Therapeutics(ATXI)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001104659-20-019770 Act: 34 Size: 36 KB 网页链接
$Avenue Therapeutics(ATXI)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001140361-19-023473 Size: 12 KB 网页链接
$Avenue Therapeutics(ATXI)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001104659-19-071669 Act: 34 Size: 35 KB 网页链接
$Avenue Therapeutics(ATXI)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001104659-19-063331 Act: 34 Size: 2 MB 网页链接
$Avenue Therapeutics(ATXI)$ 8-K - Current report Filed: 2019-11-04 AccNo: 0001104659-19-059238 Size: 89 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Avenue Therapeutics(ATXI)$ 内部交易: 2019-09-12,Director,Ingram Elizabeth Garrett ,买入,16000普通股, $6.27
$Avenue Therapeutics(ATXI)$ 8-K - Current report Filed: 2019-08-14 AccNo: 0001144204-19-039748 Size: 93 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Avenue Therapeutics(ATXI)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-08-14 AccNo: 0001144204-19-039777 Size: 2 MB 网页链接